Details for New Drug Application (NDA): 211195
✉ Email this page to a colleague
The generic ingredient in MACITENTAN is macitentan. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the macitentan profile page.
Summary for 211195
Tradename: | MACITENTAN |
Applicant: | Apotex |
Ingredient: | macitentan |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Jan 9, 2024 | TE: | RLD: | No |
Complete Access Available with Subscription